Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 30 studies | 37% ± 19% | |
smooth muscle cell | 30 studies | 58% ± 25% | |
pericyte | 26 studies | 39% ± 23% | |
endothelial cell | 22 studies | 29% ± 12% | |
astrocyte | 17 studies | 38% ± 15% | |
myofibroblast cell | 15 studies | 58% ± 17% | |
oligodendrocyte | 14 studies | 42% ± 16% | |
endothelial cell of artery | 11 studies | 28% ± 13% | |
connective tissue cell | 10 studies | 38% ± 18% | |
basal cell | 10 studies | 42% ± 11% | |
capillary endothelial cell | 9 studies | 30% ± 15% | |
conventional dendritic cell | 8 studies | 27% ± 11% | |
epithelial cell | 8 studies | 31% ± 17% | |
type I pneumocyte | 7 studies | 27% ± 13% | |
vein endothelial cell | 7 studies | 28% ± 13% | |
mesothelial cell | 6 studies | 43% ± 20% | |
ciliated cell | 6 studies | 27% ± 4% | |
endothelial cell of vascular tree | 6 studies | 38% ± 20% | |
classical monocyte | 4 studies | 23% ± 6% | |
macrophage | 4 studies | 24% ± 8% | |
glial cell | 4 studies | 26% ± 10% | |
CD8-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 28% ± 7% | |
goblet cell | 4 studies | 23% ± 6% | |
myoepithelial cell | 4 studies | 65% ± 21% | |
secretory cell | 4 studies | 36% ± 13% | |
pancreatic A cell | 3 studies | 36% ± 5% | |
non-classical monocyte | 3 studies | 31% ± 7% | |
glomerular endothelial cell | 3 studies | 28% ± 1% | |
podocyte | 3 studies | 36% ± 17% | |
type II pneumocyte | 3 studies | 23% ± 7% | |
Mueller cell | 3 studies | 24% ± 7% | |
abnormal cell | 3 studies | 34% ± 16% | |
regulatory T cell | 3 studies | 18% ± 1% | |
neuron | 3 studies | 29% ± 13% | |
muscle cell | 3 studies | 59% ± 18% | |
dendritic cell | 3 studies | 44% ± 9% | |
pancreatic ductal cell | 3 studies | 54% ± 18% | |
enteroendocrine cell | 3 studies | 32% ± 14% | |
melanocyte | 3 studies | 31% ± 11% | |
hematopoietic stem cell | 3 studies | 21% ± 5% | |
progenitor cell of mammary luminal epithelium | 3 studies | 41% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 29% ± 12% | |
lung | 6 studies | 37% ± 15% | |
intestine | 5 studies | 21% ± 6% | |
uterus | 4 studies | 39% ± 7% | |
breast | 4 studies | 27% ± 6% | |
pancreas | 3 studies | 36% ± 8% | |
peripheral blood | 3 studies | 17% ± 0% | |
prostate | 3 studies | 29% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 99% | 133710.78 | 168 / 170 | 99% | 124.25 | 456 / 459 |
prostate | 98% | 89541.45 | 241 / 245 | 100% | 245.48 | 501 / 502 |
bladder | 95% | 140348.76 | 20 / 21 | 98% | 80.55 | 495 / 504 |
lung | 93% | 34347.05 | 539 / 578 | 99% | 84.14 | 1148 / 1155 |
esophagus | 87% | 125298.08 | 1259 / 1445 | 99% | 69.71 | 182 / 183 |
intestine | 84% | 150878.39 | 813 / 966 | 99% | 73.56 | 524 / 527 |
breast | 82% | 32454.14 | 378 / 459 | 99% | 107.90 | 1112 / 1118 |
ovary | 77% | 27444.12 | 138 / 180 | 100% | 103.05 | 430 / 430 |
brain | 79% | 27632.97 | 2095 / 2642 | 95% | 117.04 | 671 / 705 |
thymus | 64% | 15424.60 | 418 / 653 | 95% | 112.19 | 577 / 605 |
stomach | 53% | 59516.30 | 191 / 359 | 100% | 96.60 | 285 / 286 |
skin | 41% | 10240.98 | 747 / 1809 | 100% | 173.52 | 471 / 472 |
kidney | 48% | 11450.73 | 43 / 89 | 93% | 48.94 | 835 / 901 |
pancreas | 1% | 254.00 | 4 / 328 | 99% | 104.46 | 177 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 93.53 | 80 / 80 |
tonsil | 0% | 0 | 0 / 0 | 100% | 54.38 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 56.68 | 1 / 1 |
blood vessel | 100% | 148377.26 | 1332 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 41.83 | 28 / 29 |
adrenal gland | 6% | 1184.44 | 15 / 258 | 75% | 39.46 | 172 / 230 |
liver | 2% | 428.52 | 5 / 226 | 74% | 32.79 | 301 / 406 |
adipose | 73% | 25551.34 | 884 / 1204 | 0% | 0 | 0 / 0 |
spleen | 46% | 10465.11 | 111 / 241 | 0% | 0 | 0 / 0 |
heart | 18% | 3609.42 | 152 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 415.41 | 13 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060537 | Biological process | muscle tissue development |
GO_0045214 | Biological process | sarcomere organization |
GO_0070527 | Biological process | platelet aggregation |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005634 | Cellular component | nucleus |
GO_0030018 | Cellular component | Z disc |
GO_0005737 | Cellular component | cytoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0042805 | Molecular function | actinin binding |
GO_0008307 | Molecular function | structural constituent of muscle |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | CSRP1 |
Protein name | Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1) (Epididymis luminal protein 141) (HEL-141) Cysteine and glycine rich protein 1 |
Synonyms | CYRP CSRP |
Description | FUNCTION: Could play a role in neuronal development. FUNCTION: Could play a role in neuronal development. . FUNCTION: Could play a role in neuronal development. . FUNCTION: Could play a role in neuronal development. . |
Accessions | ENST00000533432.5 E9PS42 ENST00000340006.7 ENST00000531916.5 A0A087X134 ENST00000526256.5 E9PND2 ENST00000526723.5 ENST00000532460.5 ENST00000367306.5 P21291 ENST00000524951.5 E9PP21 |